Pathophysiology of cancer therapy-provoked atrial fibrillation

Wan Li Cheng; Yu Hsun Kao; Shih Ann Chen; Yi Jen Chen

doi:10.1016/j.ijcard.2016.06.009

Pathophysiology of cancer therapy-provoked atrial fibrillation

Wan Li Cheng, Yu Hsun Kao, Shih Ann Chen, Yi Jen Chen

Research output: Contribution to journal › Review article › peer-review

20 Citations (Scopus)

Abstract

Atrial fibrillation (AF) occurs with increased frequency in cancer patients, especially in patients who undergo surgery or chemotherapy. AF disturbs the prognosis of cancer patients and challenges therapeutic outcomes of cancer treatment. Elucidating the mechanisms of cancer-induced AF would help identify specific strategies for preventing AF occurrence. In addition to concurrent risk factors of cancer and AF, cancer surgery, side effects of anticancer agents, and cancer-associated immune responses play critical roles in the genesis of AF. In this review, we provide succinct potential mechanisms of AF genesis in cancer patients.

Original language	English
Pages (from-to)	186-194
Number of pages	9
Journal	International Journal of Cardiology
Volume	219
DOIs	https://doi.org/10.1016/j.ijcard.2016.06.009
Publication status	Published - Sept 15 2016

Keywords

Atrial fibrillation
Cancer surgery
Chemotherapy
Proinflammatory cytokines

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ijcard.2016.06.009

Cite this

@article{5568c75d9bad478c8c2d9c68c797ad59,

title = "Pathophysiology of cancer therapy-provoked atrial fibrillation",

abstract = "Atrial fibrillation (AF) occurs with increased frequency in cancer patients, especially in patients who undergo surgery or chemotherapy. AF disturbs the prognosis of cancer patients and challenges therapeutic outcomes of cancer treatment. Elucidating the mechanisms of cancer-induced AF would help identify specific strategies for preventing AF occurrence. In addition to concurrent risk factors of cancer and AF, cancer surgery, side effects of anticancer agents, and cancer-associated immune responses play critical roles in the genesis of AF. In this review, we provide succinct potential mechanisms of AF genesis in cancer patients.",

keywords = "Atrial fibrillation, Cancer surgery, Chemotherapy, Proinflammatory cytokines",

author = "Cheng, {Wan Li} and Kao, {Yu Hsun} and Chen, {Shih Ann} and Chen, {Yi Jen}",

note = "Funding Information: The present work was supported by grants from the Ministry of Science and Technology, Taiwan ( MOST104-2811-B-038-022 , NSC102-2628-B-038-002-MY3 , MOST104-2314-B-038-071-MY3 , NSC100-2628-B-038-001-MY4 , NSC102-2314-B-038-003-MY2 , NSC102-2325-B-010-005 , and NSC102-2628-B-038-002-MY3 ), and Wan Fang Hospital, Taipei Medical University ( 104-wf-eva-01 , 104swf01 , and 105swf09 ). Publisher Copyright: {\textcopyright} 2016 Elsevier Ireland Ltd All rights reserved.",

year = "2016",

month = sep,

day = "15",

doi = "10.1016/j.ijcard.2016.06.009",

language = "English",

volume = "219",

pages = "186--194",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Pathophysiology of cancer therapy-provoked atrial fibrillation

AU - Cheng, Wan Li

AU - Kao, Yu Hsun

AU - Chen, Shih Ann

AU - Chen, Yi Jen

N1 - Funding Information: The present work was supported by grants from the Ministry of Science and Technology, Taiwan ( MOST104-2811-B-038-022 , NSC102-2628-B-038-002-MY3 , MOST104-2314-B-038-071-MY3 , NSC100-2628-B-038-001-MY4 , NSC102-2314-B-038-003-MY2 , NSC102-2325-B-010-005 , and NSC102-2628-B-038-002-MY3 ), and Wan Fang Hospital, Taipei Medical University ( 104-wf-eva-01 , 104swf01 , and 105swf09 ). Publisher Copyright: © 2016 Elsevier Ireland Ltd All rights reserved.

PY - 2016/9/15

Y1 - 2016/9/15

N2 - Atrial fibrillation (AF) occurs with increased frequency in cancer patients, especially in patients who undergo surgery or chemotherapy. AF disturbs the prognosis of cancer patients and challenges therapeutic outcomes of cancer treatment. Elucidating the mechanisms of cancer-induced AF would help identify specific strategies for preventing AF occurrence. In addition to concurrent risk factors of cancer and AF, cancer surgery, side effects of anticancer agents, and cancer-associated immune responses play critical roles in the genesis of AF. In this review, we provide succinct potential mechanisms of AF genesis in cancer patients.

AB - Atrial fibrillation (AF) occurs with increased frequency in cancer patients, especially in patients who undergo surgery or chemotherapy. AF disturbs the prognosis of cancer patients and challenges therapeutic outcomes of cancer treatment. Elucidating the mechanisms of cancer-induced AF would help identify specific strategies for preventing AF occurrence. In addition to concurrent risk factors of cancer and AF, cancer surgery, side effects of anticancer agents, and cancer-associated immune responses play critical roles in the genesis of AF. In this review, we provide succinct potential mechanisms of AF genesis in cancer patients.

KW - Atrial fibrillation

KW - Cancer surgery

KW - Chemotherapy

KW - Proinflammatory cytokines

UR - http://www.scopus.com/inward/record.url?scp=84975252131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975252131&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2016.06.009

DO - 10.1016/j.ijcard.2016.06.009

M3 - Review article

C2 - 27327505

AN - SCOPUS:84975252131

SN - 0167-5273

VL - 219

SP - 186

EP - 194

JO - International Journal of Cardiology

JF - International Journal of Cardiology

ER -

Pathophysiology of cancer therapy-provoked atrial fibrillation

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this